CrossRefPubMed 12. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–27.CrossRef 13. Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005; 365: 1543–51.CrossRef 14. Utian WH, Archer DF, Bachmann GA, et al. Estrogen and progestogen use in postmenopausal
women: July 2008 position statement of the North American Menopause KPT-8602 ic50 Society. Menopause 2008 Jul–Aug; 15 (4 Pt 1): 584–602PubMed 15. Schonberg MA, Davis RB, Wee CC. After the Women’s Health Initiative: decision making and trust of women taking hormone therapy. Womens Health Issues 2005 Jul–Aug; 15(4): 187–95CrossRefPubMed 16. McIntyre RS, Konarski JZ, Grigoriadis S, et al. Hormone replacement therapy and antidepressant prescription patterns: GDC-0068 research buy a reciprocal relationship. CMAJ 2005 Jan 4; 172 (1): 57–9.PubMed 17. Brett KM, Keenan NL. Complementary and alternative medicine use among midlife women for reasons including menopause in the United States: 2002. Menopause 2007 March–Apr; 14 (2): 300–7.CrossRefPubMed 18. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006 May 3;
295(17): 2057–71CrossRefPubMed 19. Archer DF, Seidman L, Constantine GD, et al. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. Am J Obstet Gynecol 2009 Feb; 200: 172.e1–10.CrossRef 20. Speroff L, Gass M, Constantine G, et al. Efficacy and tolerability of desvenlafaxine
succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008 Jan; 111 (1): 77–87.CrossRefPubMed 21. Archer DF, Dupont CM, Constantine GD, et al. Desvenlafaxine for the treatment of vasomotor Rucaparib cell line symptoms associated with menopause: a double-blind, randomized, placebo controlled trial of efficacy and safety. Am J Obstet Gynecol 2009 March; 200(3): 238.e1–10CrossRef 22. Evans ML, Pritts E, Vittinghoff E, et al. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005 Jan; 105 (1): 161–6.CrossRefPubMed 23. Suvanto-Luukkonen E, Koivunen R, buy KPT-330 Sundstrum H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo controlled, double-blind study. Menopause 2005 Jan–Feb; 12(1): 18–26CrossRef 24. Loprinzi CL, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 2009 Jun; 27 (17): 2831–7.CrossRefPubMed 25. Reddy SY, Warner H, Guttuso Jr T, et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006 Jul; 108 (1): 41–8.CrossRefPubMed 26. Albertazzi P, Bottazzi M, Purdie DW.